- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Global Cannabis Applications Corporation Featured in Uptick Newswire Interview
Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF) CEO Brad Moore was recently interviewed by Everett Jolly on Uptick Newswire’s “Stock Day Podcast,” where he spoke about design, development and acquisitions of mobile applications.
Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF) CEO Brad Moore was recently interviewed by Everett Jolly on Uptick Newswire’s “Stock Day Podcast,” where he spoke about design, development and acquisitions of mobile applications.
As quoted in the interview:
“Global Cannabis Applications Corp. was last on the show about a year ago. Since that time, management has redeveloped the business model which has proven very successful,” said Jolly. “The company is a multi-level data provider worldwide with offices in Canada, Lithuania, Australia and India.”
“We are trying to decode, demystify and standardize some of the approaches about medical cannabis and help put better products on shelves in a properly regulated market,” said Moore. “By providing proof of good canna data we are able to provide product producers, retailers and regulators with the ability for better product output and consumer results.”
Click here to listen to the interview.
Source: globenewswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.